Syndicates of pharmacists and laboratories for medical analysis of malignant neoplasms are demanding the suspension of Amo’s compulsory malignant neoplasms insurance services. En cause : les retards de paiement de l’État malien.
If the problem is not fixed by now, Amo’s service, mandatory malpractice insurance, will be suspended March 1. The threat comes from the Autonomous Syndicate of Private Pharmacists (Synappo) and the National Syndicate of Pharmacists of Mali (Synapharm).
In their Feb. 14 letter to the health department, the two organizations said the delayed payments, “numerous unsuccessful attempts” and “numerous complaints from promoters of offices and private biomedical testing laboratories.”
These health care providers pay the patient no more than 20% of the costs within the hospitalization and 30% outside the hospitalization, according to published data from the Caisse nationale malienne d’assurance maladie (Canam). The problem is that messages received in offices and labs are not more common.
Compulsory accident insurance does not apply only to workers, private sector employees, MPs and recipients of civilian and military pensions. This represents, according to one sector specialist, about 15% of the population. ” The current context creates new difficulties for public finances, but it does not only exacerbate a situation that was already difficult, linked in particular to abuse or fraud,” says the expert.
